Analysts, Markets Think Unilever's GSK Consumer Bid Is a Bad Idea

Unilever's shares fell nearly 7 percent on Monday after it confirmed its interest in the consumer health division of GlaxoSmithKline. Analysts think a tie-up would be unwise.